Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Aug 28;16(1):235–245. doi: 10.1111/ajt.13426

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2015 The Authors. American Journal of Transplantation published by Wiley Periodicals, Inc. on behalf of American Society of Transplant Surgeons

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Effects of immunosuppression on type 1 diabetes recurrence. Kaplan–Meier analysis of HG‐T1DR‐free survival according to the immunosuppression regimens used. Regimens used in each of the groups are shown in Table 2. Group B had a higher incidence of HG‐T1DR compared to Group D (HR = 6.324, p = 0.0036*) and Group D+E (HR = 6.058, p = 0.0011*). Group B and Group C did not differ (HR = 2.674, p = 0.3458), similar to Group A vs. Group B (HR = 3.23, p = 0.0530), Group C (HR = 1.106, p = 0.9292), and Group D+E (HR = 1.49, p = 0.4856). There was no difference in the incidence of HG‐T1DR between Group D and Group E (HR = 1.178, p = 0.8538). *Significant after correction for multiple comparisons. HG‐T1DR, hyperglycemia with type 1 diabetes recurrence.